Success Metrics

Clinical Success Rate
37.5%

Based on 3 completed trials

Completion Rate
38%(3/8)
Active Trials
3(13%)
Results Posted
133%(4 trials)
Terminated
5(22%)

Phase Distribution

Ph early_phase_1
1
4%
Ph not_applicable
13
57%
Ph phase_2
2
9%
Ph phase_1
4
17%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
1(5.0%)
Phase 1Safety & dosage
4(20.0%)
Phase 2Efficacy & side effects
2(10.0%)
N/ANon-phased studies
13(65.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

30.0%

3 of 10 finished

Non-Completion Rate

70.0%

7 ended early

Currently Active

3

trials recruiting

Total Trials

23

all time

Status Distribution
Active(3)
Completed(3)
Terminated(7)
Other(10)

Detailed Status

unknown10
Terminated5
Recruiting3
Completed3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
23
Active
3
Success Rate
37.5%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.0%)
Phase 14 (20.0%)
Phase 22 (10.0%)
N/A13 (65.0%)

Trials by Status

recruiting313%
unknown1043%
completed313%
terminated522%
withdrawn29%

Recent Activity

3 active trials
Showing 5 of 23
recruitingphase_1

Positron Emission Tomography (PET) Imaging of Thrombosis

NCT03830320
recruiting

Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

NCT06092125
withdrawnphase_2

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

NCT04271436
recruitingphase_1

Imaging Synapses With [11C] UCB-J in the Human Brain

NCT04038840
withdrawnphase_1

Does rTMS Induce Synaptic Plasticity?

NCT04311619
View all 23 trials

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT03830320Phase 1

Positron Emission Tomography (PET) Imaging of Thrombosis

Recruiting
NCT06092125

Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

Recruiting
NCT04271436Phase 2

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

Withdrawn
NCT04038840Phase 1

Imaging Synapses With [11C] UCB-J in the Human Brain

Recruiting
NCT04311619Phase 1

Does rTMS Induce Synaptic Plasticity?

Withdrawn
NCT03804424Early Phase 1

64Cu-LLP2A for Imaging Multiple Myeloma

Terminated
NCT04271254Not Applicable

PET/MR Characterization of Renal Cell Carcinomas

Terminated
NCT05003830

Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease

Unknown
NCT04605939Not Applicable

Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis

Unknown
NCT05006326Not Applicable

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Unknown
NCT04554719Not Applicable

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Unknown
NCT03739281Not Applicable

PET/MR Imaging in Lung Cancer

Terminated
NCT05466760

PET/MR Radiomics for Breast Cancer Diagnosis

Unknown
NCT04332419Not Applicable

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Completed
NCT04552847Phase 2

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Completed
NCT03076333Not Applicable

PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas

Completed
NCT04149353Not Applicable

PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo

Terminated
NCT04159376Not Applicable

Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases

Unknown
NCT04154254Not Applicable

Applying PET/MR for Dementia Applications

Unknown
NCT03657017Not Applicable

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

Unknown

Drug Details

Intervention Type
DEVICE
Total Trials
23